Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates the Severity of Idiopathic Pneumonia Syndrome in a Murine Bone Marrow Transplantation Model | Zendy

Shu-Kai Qiao | Zendy; Hanyun Ren | Zendy; Yong-Jin Shi | Zendy; Wei Liu | Zendy

Open Access

Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates the Severity of Idiopathic Pneumonia Syndrome in a Murine Bone Marrow Transplantation Model

Author(s) -

Shu-Kai Qiao,

Hanyun Ren,

Yong-Jin Shi,

Wei Liu

Publication year - 2016

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000453215

Subject(s) - medicine , transplantation , ccl5 , immunology , mesenchymal stem cell , c c chemokine receptor type 7 , bronchoalveolar lavage , foxp3 , hematopoietic stem cell transplantation , bone marrow , transplantation chimera , stem cell , lung , t cell , chemokine , il 2 receptor , inflammation , haematopoiesis , biology , pathology , chemokine receptor , immune system , hematopoietic cell , genetics

Idiopathic pneumonia syndrome (IPS) is a serious and life-threatening lung complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and currently no effective therapies exist. This study was designed to determine whether transplantation of allogeneic murine compact bone derived- mesenchymal stem cells (CB-MSCs) could prevent the development of IPS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research